This company scores below average, although its current valuation deserves attention.
Quant Score on a 1–100 scale, computed Oct 24, 3:43 PM EDT from the data shown on this page. It describes the company’s current profile — it is not a price prediction or a recommendation. How it’s calculated
Tap any area to see the numbers it is based on.
Is this a profitable, well-run business?
Not enough data to score this area.
| Input | Value | Points /10 |
|---|---|---|
| Return on equity (TTM) | — | n/a |
| Return on invested capital (TTM) | — | n/a |
| Operating margin (TTM) | — | n/a |
| Net margin (TTM) | — | n/a |
| Free cash flow / operating cash flow | — | n/a |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
The case for, the case against, and what to watch.
No area scores strongly enough to stand out.
Is the business growing, profitable and able to carry its debt?
Is the stock reasonably priced?
The stock looks expensive relative to its earnings and cash flow, so expectations are high.
A formula-based estimate from projected cash flows. Small changes in assumptions move it a lot — treat it as one input, not a price the stock will reach.
Range $8.10–$11.00. Analysts' 12-month opinions; they are frequently wrong and are not our forecast.
See how it stacks up on quality, growth, valuation, risk and momentum.
Is this a financially healthy business?
Weak. Weakest: altman z-score at -0.87.
| Input | Value | Points /10 |
|---|---|---|
| Piotroski F-Score | 5/9 | 5.0 |
| Altman Z-Score | -0.87 | 0.0 |
| Debt / Equity | — | n/a |
| Current ratio | — | n/a |
| Interest coverage | — | n/a |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock expensive?
Expensive.
| Input | Value | Points /10 |
|---|---|---|
| P/E (TTM) | — | n/a |
| PEG | — | n/a |
| Price / FCF | — | n/a |
| EV / EBITDA | — | n/a |
| DCF upside | -66.1% | 0.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the company growing?
Modest growth. Strongest signal: net income growth (fy) at 101.4%. Weakest: forward revenue growth at 5.5%.
| Input | Value | Points /10 |
|---|---|---|
| Revenue growth (FY) | 10.8% | 3.5 |
| Net income growth (FY) | 101.4% | 10.0 |
| Revenue CAGR (3Y) | 10.7% | 3.6 |
| Forward revenue growth | 5.5% | 1.8 |
| Gross margin | — | n/a |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Is the stock price showing strength?
Weak. Weakest: trend alignment (50/200 sma) at 0/3.
| Input | Value | Points /10 |
|---|---|---|
| Trend alignment (50/200 SMA) | 0/3 | 0.0 |
| RSI (14) | 33.0 | 2.0 |
| MACD histogram | -0.10 | 2.0 |
| Signal consensus | Sell | 3.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What do professional analysts think?
Mixed. Strongest signal: target upside at 58.9%. Weakest: analyst buy share at 31%.
| Input | Value | Points /10 |
|---|---|---|
| Analyst buy share | 31% | 0.1 |
| Target upside | 58.9% | 10.0 |
| 90-day rating revisions | 0↑ / 0↓ | 5.0 |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
What could go wrong?
High risk. Weakest: beta (vs. market) at 7.12.
| Input | Value | Points /10 |
|---|---|---|
| Beta (vs. market) | 7.12 | 0.0 |
| Price volatility (1Y, annualised) | 53% | 1.7 |
| Largest 1Y drawdown | -39% | 2.6 |
| Net debt / EBITDA | — | n/a |
“n/a” means the data wasn’t available; missing inputs are left out of the average, never counted as zero.
Source: Financial Modeling Prep · P/E trailing twelve months; history from annual filings · USD · data as of Oct 24, 2026
Revenue is what customers paid the company. Over 4 years it has grown about 21% a year on average.
Net income is the profit left after all costs and taxes. It has turned positive over the period shown.
Cash the business generates after investing in itself — what can fund dividends, buybacks or growth. It has been negative over the period shown.
Share of sales left after the direct cost of products.
Share of sales left after running the business.
Share of sales kept as profit.
Debt data isn't available.
Not available.
Not available (some companies have little or no debt).
Source: Financial Modeling Prep · annual filings FY2021–FY2025; margins and ratios trailing twelve months · USD · data as of Oct 24, 2026
